What do systematic reviews say?

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  13 studies · 1469 participants
  GRADE not reported

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Posterior reconstruction vs no posterior reconstruction

Posterior reconstruction showed no clear difference in urinary continence within 1 week after catheter removal MCID: 5%… compared with no posterior reconstruction (low certainty).

• Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically… 2021 · Cochrane Headline outcomes only
  RR 1.25 [0.9, 1.73]
  5 studies · 498 participants
  Low

Posterior reconstruction vs no posterior reconstruction

Posterior reconstruction showed no clear difference in urinary continence 3 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).

• Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically… 2021 · Cochrane Headline outcomes only
  RR 0.98 [0.84, 1.14]
  6 studies · 842 participants
  Low

Posterior reconstruction vs no posterior reconstruction

Posterior reconstruction showed no clear difference in serious adverse events compared with no posterior reconstruction (moderate certainty).

• Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically… 2021 · Cochrane Headline outcomes only
  RR 0.75 [0.29, 1.92]
  5 studies · 835 participants
  Moderate

Posterior reconstruction vs no posterior reconstruction

Posterior reconstruction showed no clear difference in urinary continence 6 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (moderate certainty).

• Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically… 2021 · Cochrane Headline outcomes only
  RR 1.01 [0.97, 1.05]
  5 studies · 741 participants
  Moderate

Posterior reconstruction vs no posterior reconstruction

Posterior reconstruction showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with no posterior reconstruction (low certainty).

• Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically… 2021 · Cochrane Headline outcomes only
  RR 1.02 [0.98, 1.07]
  3 studies · 602 participants
  Low

Posterior reconstruction vs no posterior reconstruction

It is very uncertain whether posterior reconstruction changes potency recovery 12 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (very low certainty).

• Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically… 2021 · Cochrane Headline outcomes only
  RR 1.02 [0.82, 1.26]
  2 studies · 308 participants
  Very low

Posterior reconstruction vs no posterior reconstruction

Posterior reconstruction showed no clear difference in positive surgical margins MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).

• Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically… 2021 · Cochrane Headline outcomes only
  RR 1.24 [0.65, 2.33]
  3 studies · 517 participants
  Low

Blue light vs white light

Blue light may leads to lower time to disease recurrence (absolute event rates based on 12 months compared with white light (low certainty).

• Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer 2021 · Cochrane Headline outcomes only
  HR 0.66 [0.54, 0.81]
  15 studies · 2994 participants
  Low

Blue light vs white light

Blue light may leads to lower time to disease progression (absolute event rates based on 12 months compared with white light (low certainty).

• Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer 2021 · Cochrane Headline outcomes only
  HR 0.65 [0.5, 0.84]
  9 studies · 2200 participants
  Low

Blue light vs white light

Blue light showed no clear difference in surgical complications, serious (up to 90 days; MCID 2%) compared with white light (low certainty).

• Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer 2021 · Cochrane Headline outcomes only
  RR 0.54 [0.14, 2.14]
  1 study · 525 participants
  Low

Blue light vs white light

Blue light showed no clear difference in time to death from bladder cancer (absolute event rates based on 60… compared with white light (low certainty).

• Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer 2021 · Cochrane Headline outcomes only
  HR 0.55 [0.19, 1.61]
  1 study · 407 participants
  Low